Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Sees Significant Growth in Short Interest

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 5,220,000 shares, a growth of 6.3% from the March 31st total of 4,910,000 shares. Based on an average trading volume of 802,900 shares, the days-to-cover ratio […]

Related Keywords

China ,Stephanie Okey ,Richard Scott Struthers ,Robertw Baird ,Crinetics Pharmaceuticals Inc ,Nasdaq ,China Universal Asset Management Co ,Crinetics Pharmaceuticals Stock Performance ,Cantor Fitzgerald ,Securities Exchange Commission ,Highmark Wealth Management ,Citigroup ,Institutional Trading Of Crinetics Pharmaceuticals ,Fisher Asset Management ,Hennion Walsh Asset Management Inc ,Crinetics Pharmaceuticals ,Insider Transactions At Crinetics Pharmaceuticals ,News Ratings For Crinetics Pharmaceuticals Daily ,Morgan Stanley ,Vanguard Group Inc ,Get Free Report ,Scott Struthers ,Exchange Commission ,Director Stephanie Okey ,Universal Asset Management ,Mark Wealth Management ,Walsh Asset Management ,Asset Management ,Crinetics Pharmaceuticals Daily ,Nasdaq Crnx ,Crnx ,Medical ,Stocks ,Options ,Put ,Call ,